Advances in Biocatalysis for Sustainable Pharmaceutical Synthesis: Applications, Technological Progress, and Future Directions

Biocatalysis has emerged as a critical tool in pharmaceutical synthesis, offering a range of significant advancements in recent years. This paper provides a comprehensive review of biocatalysis applications in drug synthesis, emphasizing its role in enhancing the efficiency and environmental sustainability of producing complex pharmaceutical molecules. Through detailed case studies, including the biocatalytic synthesis of amoxicillin, paclitaxel, and ribavirin, the paper illustrates the superior reaction efficiency, selectivity, and reduced environmental impact achievable through biocatalysis. The technological advancements discussed include optimizing enzyme activity via genetic engineering, enhancing enzyme stability through covalent modification, and applying enzyme immobilization techniques. Furthermore, the integration of biocatalysis with green chemistry principles is explored, highlighting its potential to reduce harmful byproducts and energy consumption in industrial processes. The paper also delves into the future directions and challenges of scaling biocatalysis for broader industrial application. As an integral part of green chemistry, biocatalysis is poised to play a pivotal role in promoting sustainable development and minimizing environmental impact in the pharmaceutical industry.